Industry

Middle East and Africa Dietary Supplements Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Vitamins, Minerals, Proteins and Amino Acids, Probiotics, Blends, and Others), Form (Tablets, Capsules and Softgels, Powders, and Others), and Distribution Channel (Supermarkets and Hypermarkets, Specialty Stores, Online Retail, and Others)

Report Code : 

TIPRE00027460

No. of Pages : 117
Published Month : Mar 2022
Category : Consumer Goods

The MEA dietary supplements market is expected to grow from US$ 9,551.77 million in 2021 to US$ 14,646.02 million by 2028; it is estimated to grow at a CAGR of 6.3% from 2021 to 2028.

In recent years, the market has experienced various technological advancements. For instance, traditional hard and soft gelatin capsules, lozenges, tablets, powders, and liquids are joined by several other types of supplement forms, such as gummies, bilayer tablets, or granules. Due to increased product innovation and rising consumer desire for personalization in the supplement sector, consumers now have access to a diverse selection of delivery forms to suit their specific lifestyles and preferences, providing the industry with the option to solve swallowing issues and cater to increased consumer demand for customization. As a result, manufacturers are focusing on innovations and are launching new products in different forms and flavors.  Furthermore, in April 2019, Amway introduced a new probiotic supplement named Nutrilite Balance Within. This product is a dietary supplement that helps the human body with clinically established probiotic levels for gut and immunological health. Due to these trends and factors, the MEA dietary supplements market is expected to witness new opportunities for growth in the near future.   

In the MEA region, Turkey, South Africa, Iraq, and Israel are among the major countries with a high number of COVID-19 confirmed cases and deaths. According to the International Finance Corporation, the COVID-19 pandemic has a severe impact on the economy of the MEA which has led to declining oil production, tourism, and remittances. The quarantine measures implemented for sanitary purposes in the region have led to a standstill of several activities across diverse economic sectors. The MEA region comprises many growing economies, which are prospective markets for dietary supplements vendors. The pandemic has significantly increased the growth of the dietary supplements market in the region due to various health benefits associated with it and it also helps in improving the immune system against COVID-19.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA dietary supplements market. The MEA dietary supplements market is expected to grow at a good CAGR during the forecast period. 

MEA Dietary Supplements Market Revenue and Forecast to 2028 (US$ Million)

MEA Dietary Supplements Market Segmentation

MEA Dietary Supplements Market – By Type

  • Vitamins
  • Minerals
  • Proteins and Amino Acids
  • Probiotics
  • Blends
  • Others

MEA Dietary Supplements Market – By Form

  • Tablets
  • Capsules and Softgels
  • Powders
  • Others

MEA Dietary Supplements Market – By Distribution Channel

  • Supermarkets and Hypermarkets
  • Specialty Stores
  • Online Retail
  • Others

MEA Dietary Supplements Market, by Country

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

MEA Dietary Supplements Market - Companies Mentioned

  • Abbott
  • Amway Corp.
  • Bayer AG
  • Bionova
  • GlaxoSmithKline plc. 
  • Otsuka Holdings Co., Ltd
  • Pfizer Inc. 
  • The Bountiful Compan

Middle East and Africa Dietary Supplements Report Scope

Report Attribute Details
Market size in 2021 US$ 9,551.77 Million
Market Size by 2028 US$ 14,646.02 Million
Global CAGR (2021 - 2028) 6.3%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • Vitamins
  • Minerals
  • Proteins and Amino Acids
  • Probiotics
  • Blends
By Form
  • Tablets
  • Capsules and Softgels
  • Powders
By Distribution Channel
  • Supermarkets and Hypermarkets
  • Specialty Stores
  • Online Retail
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott
  • Amway Corp.
  • Bayer AG
  • Bionova
  • GlaxoSmithKline plc.
  • Otsuka Holdings Co., Ltd
  • Pfizer Inc.
  • The Bountiful Company
    1. Abbott
    2. Amway Corp.
    3. Bayer AG  
    4. Bionova
    5. GlaxoSmithKline plc. 
    6. Otsuka Holdings Co., Ltd
    7. Pfizer Inc.
    8. The Bountiful Company
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA dietary supplements market.    
    • Highlights key business priorities in order to assist companies to realign their business strategies
    • The key findings and recommendations highlight crucial progressive industry trends in the MEA dietary supplements market, thereby allowing players across the value chain to develop effective long-term strategies
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
    • Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the dietary supplements market, as well as those hindering it   
    • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution    
    Download Sample